Disclosure of shareholdings in accordance with Art. 20 SESTA

Liestal, Switzerland - Santhera Pharmaceuticals (SWX: SANN) was informed by Cominvest Asset Management GmbH, Platz der Einheit 1, 60327 Frankfurt am Main, Germany, that several public and non-public funds under its management hold a total of 178,000 registered shares of Santhera Pharmaceuticals Holding AG, representing 6.03 % of the voting rights of the shares registered in the Commercial Register.

 

Thomas Staffelbach, VP Public & Investor Relations

Phone: +41 (0) 61 906 89 47